A well-intentioned drug pricing reform under the Inflation Reduction Act (IRA) could lead to higher out-of-pocket costs and serious health risks for Medicare patients—despite its goal to lower drug prices. The post Lower Prices, Higher Risk: How Drug Reform Could Backfire on Patients appeared first on CreakyJoints.| CreakyJoints
By Angie Ebba| CreakyJoints
If you live with certain forms of arthritis, you may be considered at a higher risk for potential COVID-19 complications. Get expert advice here.| CreakyJoints